Clinical Trials
2 trialsNCT03263429 2024-08-30
Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer
Vanderbilt-Ingram Cancer Center
Phase 1/2 Completed
NCT01828047 2015-03-17
Sublingual Microcirculation and Postoperative Ileus
McGill University Health Centre/Research Institute of the McGill University Health Centre
Completed